Clinical Trials Insight: 700038864

Trial Profile

Clinical Trials Insight: 700038864

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2010

At a glance

  • Drugs Phenelzine; Rasagiline; Selegiline
  • Indications Parkinson's disease
  • Focus Pharmacodynamics; Registrational
  • Sponsors Teva Pharmaceutical Industries
  • Most Recent Events

    • 03 Jun 2010 Results of this trial have been published in the Journal of Clinical Pharmacology, according to a Teva Neuroscience media release.
    • 05 May 2010 Results published in the Journal of Clinical Pharmacology.
    • 09 Jun 2009 Results reported at 13th International Congress of Parkinson's Disease and Movement Disorders (PDMD), according to a Teva Neuroscience media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top